Doreen L. Weller - Concepedia

Author

Doreen L. Weller

Sarepta Therapeutics (United States)

Also Known As

D Weller, D. L. WELLER, D. WELLER, D. Weller, DOREEN L. WELLER, DWIGHT WELLER, Doreen L. Weller

Publications

847

Citations

H-Index

Concepts

All Affiliations

Sarepta Therapeutics (United States)Oregon State University MPI Research (United States)Corvallis Environmental Center University of Stuttgart

About

Doreen L. Weller is an author at Sarepta Therapeutics (United States) specializing in pharmacology, natural sciences, and organic chemistry.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	5	5	192
2	Natural Sciences	5	5	144
3	Biochemistry	4	4	118
4	Engineering	1	1	17
5	Biomolecular Engineering	1	1	13

Doreen L. Weller

Publications

684

Citations

H-Index

Page 1

	Year	Citations
Resistance of Morpholino Phosphorodiamidate Oligomers to Enzymatic Degradation Robert M. Hudziak, Elisabeth Barofsky, Douglas F. Barofsky, Antisense and Nucleic Acid Drug Development	1996	266
<i>In vivo</i> Bioavailability and Pharmacokinetics of a <i>c-MYC</i> Antisense Phosphorodiamidate Morpholino Oligomer, AVI-4126, in Solid Tumors Gayathri R. Devi, Tomasz M. Beer, Christopher L. Corless, Clinical Cancer Research	2005	109
Total synthesis of of4949-III, a natural inhibitor of aminopeptidase B from ehrlich ascites carcinoma cells Ulrich Schmidt, Doreen L. Weller, Alvin A. Holder, Tetrahedron Letters Medicinal ChemistryBiochemistryNatural SciencesMedicineTotal Synthesis	1988	58
Repeat-Dose Toxicology Evaluation in Cynomolgus Monkeys of AVI-4658, a Phosphorodiamidate Morpholino Oligomer (PMO) Drug for the Treatment of Duchenne Muscular Dystrophy Peter Sazani, Kirk P. Van Ness, Doreen L. Weller, International Journal of Toxicology Translational MedicineUrologyPharmacological StudyCynomolgus MonkeysDuchenne Muscular Dystrophy	2011	49
Safety Pharmacology and Genotoxicity Evaluation of AVI-4658 Peter Sazani, Doreen L. Weller, Stephen B. Shrewsbury International Journal of Toxicology Drug SafetySafety PharmacologyExon SkippingDmd PatientsMedicine	2010	41
Chemical and Mechanistic Toxicology Evaluation of Exon Skipping Phosphorodiamidate Morpholino Oligomers in <i>mdx</i> Mice Peter Sazani, Kirk P. Van Ness, Doreen L. Weller, International Journal of Toxicology Molecular PharmacologyExon SkippingUrologyMdx MiceBiochemistry	2011	31
Synthesis of 3-methyl-5,6-dihydro-3H-benzofuro[3,2-e]isoquinolin-7(7aH)-ones Dwight D. Weller, Eugene P. Stirchak, Doreen L. Weller The Journal of Organic Chemistry Medicinal ChemistryMolecular SciencesDerivative (Chemistry)Donut IconNatural Sciences	1983	26
Antibacterial Activity and Inhibition of Protein Synthesis in <i>Escherichia coli</i> by Antisense DNA Analogs Mohammad Alinoor Rahman, James E. Summerton, E. A. Foster, Antisense Research and Development	1991	24
Total synthesis of ulithiacyclamide Ulrich Schmidt, Doreen L. Weller Tetrahedron Letters Total SynthesisOrganic ChemistryStereoselective SynthesisPharmacologySynthetic Chemistry	1986	20
Synthesis of 4-arylpyridines Dwight D. Weller, Glenn R. Luellen, Doreen L. Weller The Journal of Organic Chemistry AltmetricsEngineering4-Arylpyridinesdwight D. WellerInformationAltmetric Attention Score	1982	17

Page 1